We provide fully customized services tailored to your specific project needs. Our experts will work with you to optimize assay design, select relevant analytes, and ensure the workflow aligns perfectly with your research goals.
Creative Biolabs is expertise in the mechanism of T cell antigen recognition and is experienced in applying immunological technologies for antigen discovery. Now, we provide high-throughput multiplexed assays to identify T-cell epitopes for basic and translational research, such as drugs and vaccine design for infectious diseases.
Multiple approaches are utilized to develop a high-throughput multiplexed method to explore a large scale of potential epitopes in the antigen protein. Most of the approaches display the peptide-MHC complex on cells, such as tumor cells, yeast, or baculovirus, and co-culture with cognate T cells or use soluble TCRs to assess T cell binding and activation. Recently, a team delivered the genome-wide antigen to cells and processed it by endogenous MHC-I molecules to imitate the natural antigen-presented pathway and use the granzyme B activity as the effector molecule to monitor T-cell responses.
Discover how we can help - Request a consultation.
Fig.1 Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries.1
We provide fully customized services tailored to your specific project needs. Our experts will work with you to optimize assay design, select relevant analytes, and ensure the workflow aligns perfectly with your research goals.
Our high-throughput platform is designed to handle the most demanding projects. We can screen thousands of samples and measure dozens of analytes in a fraction of the time required by conventional methods, ensuring you get the data you need faster.
We provide the following popular cytokine and chemokine release measurement services to monitor T cell responses.
| Multiple Analytes Available | |||||||
|---|---|---|---|---|---|---|---|
| IL-1b | IL-2 | IL-3 | IL-4 | IL-5 | IL-6 | IL-8 | IL-10 |
| IL-12 | IL-13 | IL-17 | IL-17A | IL-22 | IL-23 | IFNγ | IFNβ |
| TNF | TNFα | GM-CSF | TGFβ | CXCL10/IP-10 | CCL4/MIP-1b | CXCL9/MIG | CCL3/MIP-1a |
| TNFβ | |||||||
At Creative Biolabs, we provide a systematic high-throughput antigen genome screening assay to identify cancer epitopes associated with T cell immunity, providing potential targets for diagnostics, antibody-mediated therapy, and vaccine development.
A method that comprehensively profiles cancer antigens is crucial for identifying T cell epitopes that are physiologically meaningful in vivo. We have developed a high-throughput technology to construct an ORF library covering the entire coding domain of cancer antigens. In detail, each OFR is cloned into our vector and expressed using in vitro transcription/translation kit.
PBMCs are stimulated with full-length antigens to produce enough antigen-specific T cells. The specific T cells are cultured to more than 10 billion, and CD4+, CD8+ T cells are sorted for the following screening.
Expanded CD4+ T cells are co-cultured with the synthesized antigen protein library and cognate antigen-presenting cells (APC).
Expanded CD8+ T cells are mixed with antigen proteins presented by artificial APCs that are generated from HLA cDNA and peptides co-transfected COS-7 cells.
A read-out assay, such as a 3H-thymidine incorporation assay or an ELISpot assay for cytokine secretion, is adopted to screen the antigen-specific responses.
Fig.2 Screening results of IFNγ-release ELISpot.1
Our team comprises experienced immunologists and bioinformaticians who are dedicated to delivering accurate, high-quality data. We use state-of-the-art bead-based and microfluidic technology to minimize technical bias and ensure the reproducibility of your results.
Our proprietary platform allows for the rapid, simultaneous quantification of dozens of biomarkers from a single, minute sample volume. This high-throughput capability drastically reduces your experimental time and resource consumption, accelerating your research timelines.
Unlike single-plex assays, our multiplexed platform provides a rich, holistic view of the T-cell response. We deliver comprehensive data reports and a final scientific summary, complete with expert insights and recommendations to advance your project.
Our team works closely with you to understand your unique project needs, offering fully customized assay panels and experimental designs. From initial consultation to final data delivery, we are your trusted partner in discovery.
Discover how Creative Biolabs' T cell-based high-throughput multiplexed assay can streamline your research - Get a quote today.
One of the key benefits of our technology is its low sample volume requirement. It can quantify dozens of biomarkers from a single, minute sample, making it ideal for studies with limited clinical material.
Our assay incorporates advanced bead-based and microfluidic technology designed to ensure high data quality and reproducibility. We have robust quality control checks at every stage of the workflow, and our experienced team carefully reviews all data to ensure accuracy.
Our platform utilizes high-throughput plates to analyze multiple samples and screen a panel of peptides for immunodominant epitopes, providing accurate and reliable data.
Learn More →A powerful technique that combines ELISA with flow cytometry to simultaneously test multiple analytes. This assay is highly sensitive, allowing for the analysis of up to 30 different proteins from a small sample volume.
Learn More →Our T cell-based high-throughput multiplexed assay helps you accelerate your immunotherapy research by providing comprehensive, high-resolution data at an unprecedented scale through our advanced multiplexing and automation technologies.
Contact us today to discuss your project needs and discover how our T cell-based high-throughput multiplexed assay can help you achieve your goals faster.
Reference